Shared on02 Aug 25Fair value Increased 5.22%
The consensus price target for Acutaas Chemicals has increased to ₹1466, primarily reflecting a significant upgrade in revenue growth expectations to 32.0% per annum, despite a decline in net profit margin. What's in the News Board meeting scheduled to consider and approve unaudited standalone and consolidated financial results for Q1 ended June 30, 2025.
Shared on01 May 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on24 Apr 25Fair value Increased 0.74%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 7.83%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 5.43%
AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.